Data coverage, completeness and provenance for BIOTRON LIMITED in the Stock Market API — Health Care · Biotechnology.
Source date: 2026-10-30T03:34:33. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-10-30 | 0.0020 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-29 | 0.0020 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-28 | 0.0020 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-27 | 0.0020 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-26 | 0.0020 | AUD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/BIT/prices · Price parameters and adjustment semantics
Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225 that is in Phase 2 clinical trial for the treatment of HIV-1, as well as to treat hepatitis C virus infections; and BIT-HBV001 to treat hepatitis B virus and hepatitis delta virus. It also develops preclinical drugs for viral diseases, such as dengue, zika, and influenza virus. The company was incorporated in 1999 and is based in Sydney, Australia.
Website: https://www.biotron.com.au · Profile fields populated: 60%
Share of stored fields populated in the anchor reporting period (FY2026), primary source yfinance. Full per-field breakdown: GET /api/v1/companies/BIT/financials.
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2026 (AUD) | 2026-06-30 | 23 | yfinance | ||||
| FY2024 (AUD) | 2024-06-30 | 23 | yfinance | ||||
| FY2023 (AUD) | 2023-06-30 | 23 | yfinance | ||||
| FY2022 (AUD) | 2022-06-30 | 23 | yfinance |
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/BIT
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/BIT/financials
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/BIT/metrics/summary
Report PDFs with LLM-ready markdown conversions where available.
GET /api/v1/companies/BIT/filings
Dated press releases and announcements with source links.
GET /api/v1/companies/BIT/news
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/BIT
Free tier — instant API key. Built for AI agents.